Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$109M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$89.4M |
| 3 |
JPMorgan Chase
JPM
|
+$82.7M |
| 4 |
Intel
INTC
|
+$73.6M |
| 5 |
Boston Scientific
BSX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$193M |
| 2 |
RTX Corp
RTX
|
+$170M |
| 3 |
PNC Financial Services
PNC
|
+$126M |
| 4 |
ExxonMobil
XOM
|
+$121M |
| 5 |
Bank of America
BAC
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.65% |
| 2 | Technology | 14.28% |
| 3 | Financials | 13.93% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
PUT
Harley-Davidson
HOG
$2.93B
| $1.89M | 0.02% |
+100,000
| New | +$3.03M |
|
627
CALL
Stride
LRN
$3.51B
| $1.89M | 0.02% |
+100,000
| New | +$1.84M |
|
|
CADE
628
DELISTED
Cadence Bancorporation
CADE
| $1.87M | 0.02% |
284,817
+208,283
| +272% | +$2.87M |
|
|
COUP
629
DELISTED
Coupa Software Incorporated
COUP
| $1.85M | 0.02% |
13,211
+3,177
| +32% | +$492K |
|
630
The RMR Group
RMR
$342M
| $1.83M | 0.02% |
+67,874
| New | +$2.63M |
|
631
iShares 20+ Year Treasury Bond ETF
TLT
$46.3B
| $1.83M | 0.02% |
+11,099
| New | +$1.65M |
|
632
DuPont de Nemours
DD
$18.7B
| $1.82M | 0.02% |
42,550
-248,175
| -85% | -$15.2M |
|
|
CHNG
633
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $1.81M | 0.02% |
+181,671
| New | +$2.54M |
|
634
CALL
BioCryst Pharmaceuticals
BCRX
$2.44B
| $1.8M | 0.02% |
+900,000
| New | +$2.48M |
|
635
Wynn Resorts
WYNN
$10.3B
| $1.8M | 0.02% |
+29,904
| New | +$3.35M |
|
636
Littelfuse
LFUS
$10.5B
| $1.78M | 0.02% |
13,366
+7,289
| +120% | +$1.22M |
|
|
S
637
DELISTED
Sprint Corporation
S
| $1.78M | 0.02% |
+206,039
| New | +$1.45M |
|
638
Glacier Bancorp
GBCI
$6.15B
| $1.75M | 0.02% |
51,325
-36,580
| -42% | -$1.46M |
|
|
STL
639
DELISTED
Sterling Bancorp
STL
| $1.73M | 0.02% |
+165,697
| New | +$2.86M |
|
|
MPT
640
PUT
Medical Properties Trust
MPT
$2.46B
| $1.73M | 0.02% |
+100,000
| New | +$2.09M |
|
641
Camping World
CWH
$676M
| $1.72M | 0.02% |
+302,378
| New | +$3.8M |
|
642
Annaly Capital Management
NLY
$17.5B
| $1.71M | 0.02% |
84,447
-859,828
| -91% | -$30.2M |
|
|
SHOE
643
Shoe Station Group
SHOE
$420M
| $1.71M | 0.02% |
164,548
-26,016
| -14% | -$409K |
|
|
FITB
644
CALL
Fifth Third Bancorp
FITB
$49.7B
| $1.71M | 0.02% |
+115,000
| New | +$2.87M |
|
|
FTSV
645
CALL
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $1.71M | 0.02% |
+17,900
| New | +$1.08M |
|
|
ENV
646
DELISTED
ENVESTNET, INC.
ENV
| $1.7M | 0.02% |
31,616
+5,731
| +22% | +$411K |
|
647
Crocs
CROX
$5.85B
| $1.7M | 0.02% |
99,884
-102,825
| -51% | -$3.28M |
|
|
VIVO
648
DELISTED
Meridian Bioscience Inc
VIVO
| $1.69M | 0.02% |
+200,587
| New | +$1.69M |
|
649
BellRing Brands
BRBR
$1.18B
| $1.66M | 0.02% |
97,417
-145,232
| -60% | -$2.94M |
|
|
CARO
650
DELISTED
Carolina Financial Corp.
CARO
| $1.66M | 0.02% |
+64,206
| New | +$2.24M |
|
Similar funds
Dmitry Balyasny's Q1 2020 Portfolio in Review
As of Q1 2020, Dmitry Balyasny held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
Against the trend, Dmitry Balyasny opened a new position in Lowe's Companies worth $86M.
- Dmitry Balyasny's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
- Dmitry Balyasny added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
- Dmitry Balyasny's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
- Dmitry Balyasny fully exited American International in Q1 2020, selling an estimated $193M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
- Dmitry Balyasny opened 583 new positions and closed 598 in Q1 2020.
- Dmitry Balyasny's portfolio value fell 50% quarter-over-quarter to $8.43B.
Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.